EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts

Guangshuai Teng, Minghui Duan, Ke Shang, Yuhui Zhang, Xiaojing Wei, Lan Peng, Gary Tse, Yuan Zhou, Gregory Y H Lip, Tong Liu, Jie Bai

Journal of Thrombosis and Haemostasis · 2026-01 · 24 (1) · 216-226

DOI: 10.1016/j.jtha.2025.09.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-01. Verfasst von Guangshuai Teng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second H…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Interleukin-1beta, DNA-Binding Proteins, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Municipal Education Committee, Tianjin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The role of clonal hematopoiesis of indeterminate potential (CHIP) related gene mutations in atrial fibrillation (AF) and stroke in patients with myeloproliferative neoplasms (MPNs) remains insufficiently investigated. OBJECTIVES: To investigate the role of CHIP related gene mutations in AF and stroke in patients with MPNs and explore the role of cytokines. METHODS: A retrospective cohort of 465 MPN patients (mean age 61; range, 10-89; 49% male) and an additional validation cohort (n = 196) were analyzed using multivariable Cox regression, Firth-corrected Cox regression, and competing risks models, adjusting for confounders. Propensity score matching (PSM) balanced confounders. Mediation analysis assessed the role of IL-1β in the link between TET2 and AF/stroke. RESULTS: CHIP-related mutations increased the risk of AF in all 3 models, both before and after PSM. TET2 independently increased the risk of AF (Cox, hazard ratio [HR] = 3.13; 95% CI, 1.62, 6.06; P = .001; Firth, HR = 3.03; 95% CI, 1.55, 5.74; P = .002; Fine-Gray, subdistribution HR = 2.98; 95% CI, 1.46, 6.08; P = .003). Sensitivity analysis in the JAK2 subgroup and PSM cohort, as well as the validation cohort, all confirmed that TET2 remained associated with AF (all P < .05). Interleukin (IL)-1β partially mediated the association between TET2 and AF (P = .034). AF predicted the occurrence of stroke (P < .05) and partially mediated the relationship between TET2 and stroke. No direct association between CHIP/TET2 and stroke was observed, and IL-1β did not play a role in the association between TET2 and stroke. CONCLUSION: TET2 mutations increase the risk of AF, which may be associated with the IL-1β-mediated inflammatory pathway. AF serves as a critical intermediary for CHIP-associated ischemic stroke. Integrating TET2 status into AF surveillance and anticoagulation strategies may reduce thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationInterleukin-1betaDNA-Binding ProteinsMutationStrokeProto-Oncogene ProteinsMyeloproliferative DisordersHumansMaleDioxygenasesFemaleMiddle AgedAgedRetrospective StudiesAged, 80 and overRisk FactorsAdultAdolescentYoung AdultRisk AssessmentGenetic Predisposition to Disease

Stichwörter der Autor:innen

TET2atrial fibrillationcytokinesmyeloproliferative neoplasmsstroke

Substanzen

TET2 protein, humanDioxygenasesInterleukin-1betaDNA-Binding ProteinsIL1B protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China; Department of H…
  • Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin, China.
  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China; School of Nursi…
  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK; Danish Center for Health Services Research, Department of Cli…

Förderung

  • Tianjin Municipal Education Committee
  • Tianjin Medical University

Zitieren

APA

Teng, G., Duan, M., Shang, K., Zhang, Y., Wei, X., Peng, L., Tse, G., Zhou, Y., Lip, G. Y. H., Liu, T., & Bai, J. (2026). TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts. Journal of Thrombosis and Haemostasis, 24(1), 216-226. https://doi.org/10.1016/j.jtha.2025.09.015

Vancouver

Teng G, Duan M, Shang K, Zhang Y, Wei X, Peng L, et al. TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts. Journal of Thrombosis and Haemostasis. 2026;24(1):216-226. doi:10.1016/j.jtha.2025.09.015

BibTeX
@article{Teng2026,
  author = {Teng, Guangshuai and Duan, Minghui and Shang, Ke and Zhang, Yuhui and Wei, Xiaojing and Peng, Lan and Tse, Gary and Zhou, Yuan and Lip, Gregory Y H and Liu, Tong and Bai, Jie},
  title = {TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {216--226},
  doi = {10.1016/j.jtha.2025.09.015}
}
Kostenlos starten →